ImageneBio (IMA) Non-Current Assets (2020 - 2025)

ImageneBio has disclosed Non-Current Assets across 6 years of filings, most recently posting $12.7 million for Q4 2025.

• Non-Current Assets for Q4 2025 came in at $12.7 million, up 267.34% year-over-year; the trailing twelve-month figure through Dec 2025 was $67.0 million (up 118.4% YoY), and the FY2025 annual result was $12.7 million, up 267.34% from the prior year.
• Non-Current Assets came in at $12.7 million for Q4 2025 at ImageneBio, down from $13.3 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $27.2 million in Q2 2025 to a low of $3.5 million in Q4 2024.
• The 5-year median for Non-Current Assets is $11.7 million (2022), against an average of $11.9 million.
• Across the five-year window, Non-Current Assets jumped 366.65% in 2021 and sank 74.28% in 2024, its largest moves.
• ImageneBio's Non-Current Assets stood at $11.4 million in 2021, then gained by 7.8% to $12.2 million in 2022, then gained by 9.64% to $13.4 million in 2023, then sank by 74.28% to $3.5 million in 2024, then soared by 267.34% to $12.7 million in 2025.
• The last three Non-Current Assets figures came in at $12.7 million (Q4 2025), $13.3 million (Q3 2025), and $27.2 million (Q2 2025), per Business Quant data.